Syngene International (NSE:SYNGENE) 3-Year Revenue Growth Rate : 18.50% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Syngene International 3-Year Revenue Growth Rate?

Syngene International's Revenue per Share for the three months ended in Mar. 2024 was ₹22.85.

During the past 12 months, Syngene International's average Revenue per Share Growth Rate was 9.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 18.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 16.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Syngene International was 25.30% per year. The lowest was 12.90% per year. And the median was 18.50% per year.

Competitive Comparison of Syngene International's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Syngene International's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syngene International's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Syngene International's 3-Year Revenue Growth Rate falls into.

Syngene International 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Syngene International (NSE:SYNGENE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Syngene International 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Syngene International's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Syngene International (NSE:SYNGENE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

539268:India

Address

Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099

Website

https://www.syngeneintl.com

Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines